rs12029454 - NOS1AP

Magnitude 4.5 · 3 studies on file

Reported associations

  • Genetic analyses of diverse populations improves discovery for complex traits - Unknown journal (n.d.) · Unknown authors · PubMed 31217584

    ABSTRACT: Genome-wide association studies (GWAS) have laid the foundation for investigations into the biology of complex traits, drug development and clinical guidelines. However, the majority of discovery efforts are based on data from populations of European ancestry. In light of the differential genetic architecture that is known to exist between populations, bias in representation can exacerbate existing disease and healthcare disparities. Critical variants may be missed if they have a low frequency or are completely absent in European populations, especially as the field shifts its attention towards rare variants, which are more likely to be population-specific. Additionally, effect sizes and their derived risk prediction scores derived in one population may not accurately extrapolate

  • Common variants at ten loci influence myocardial repolarization: the QTGEN consortium - Unknown journal (n.d.) · Unknown authors · PubMed 19305408

    ABSTRACT: QT interval duration reflecting myocardial repolarization on the electrocardiogram is a heritable risk factor for sudden cardiac death and drug-induced arrhythmias. We conducted a meta-analysis of 3 genome-wide association studies in 13,685 individuals of European ancestry from the Framingham Heart Study, the Rotterdam Study and the Cardiovascular Health Study. We observed associations at P < 5×10−8 with variants in NOS1AP, KCNQ1, KCNE1, KCNH2 and SCN5A, known to be involved in myocardial repolarization and Mendelian Long QT Syndromes. Associations at five novel loci included 16q21 near NDRG4 and GINS3, 6q22 near PLN, 1p36 near RNF207, 16p13 near LITAF and 17q12 near LIG3 and RIFFL. Collectively, the 14 independent variants at these 10 loci explain 5.4-6.5% of variation in Q

  • Genetic architecture of bone marrow fat fraction implies its involvement in osteoporosis risk - Unknown journal (n.d.) · Unknown authors · PubMed 40796918

    ABSTRACT: Bone marrow adipose tissue, as a distinct adipose subtype, has been implicated in the pathophysiology of skeletal, metabolic, and hematopoietic disorders. To identify its underlying genetic factors, we utilized a deep learning algorithm capable of quantifying bone marrow fat fraction (BMFF) in the vertebrae and proximal femur using magnetic resonance imaging data of over 38,000 UK Biobank participants. Genome-wide association analyses uncovered 373 significant BMFF-associated variants (P-value < 5 × 10−9), with enrichment in bone remodeling, metabolism, and hematopoiesis pathway. Furthermore, genetic correlation highlighted a significant association between BMFF and skeletal disease. In about 300,000 individuals, polygenic risk scores derived from three proximal femur BMFF


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • Genetic QT prolongation and sudden cardiac death risk stratification Moderate

    rs12029454 A-allele carriers have heritable QT interval prolongation that contributes to sudden cardiac death risk at population level

Drug interactions

  • QT-prolonging medications without cardiology review Moderate

    Genetically prolonged QT from rs12029454 increases susceptibility to drug-induced ventricular arrhythmia when combined with QT-prolonging medications

    Inform all healthcare providers of this genetic variant; verify new medications are not QT-prolongers before use

Screening

  • Baseline electrocardiogram (ECG) and QT interval assessment Moderate

    rs12029454 A-allele carriers show significantly prolonged QT intervals (effect=0.17-0.21 SD per allele copy), a measured phenotype independently associated with sudden cardiac death risk

    Obtain baseline ECG to establish QT interval duration; discuss findings with cardiologist for monitoring intervals